Reproductive Safety of Lurasidone and Quetiapine: Update from the National Pregnancy Registry for Psychiatric Medications.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of women's health"
DOI: 10.1089/jwh.2022.0310
Abstract: Background: Second-generation antipsychotics (SGAs), also called atypical antipsychotics, are common therapies for women with a spectrum of psychiatric disorders. No systematically ascertained human reproductive safety data are available for lurasidone, and prospective data for quetiapine… read more here.
Keywords: quetiapine; reproductive safety; lurasidone quetiapine; pregnancy ... See more keywords
A Candidate Gliotransmitter, L-β-Aminoisobutyrate, Contributes to Weight Gain and Metabolic Complication Induced by Atypical Antipsychotics
Sign Up to like & getrecommendations! Published in 2023 at "Nutrients"
DOI: 10.3390/nu15071621
Abstract: Lurasidone and quetiapine are effective atypical mood-stabilizing antipsychotics, but lurasidone and quetiapine are listed as lower-risk and high-risk for weight gain/metabolic complications, respectively. The pathophysiology of the discrepancy of metabolic adverse reactions between these antipsychotics… read more here.
Keywords: baiba enantiomer; baiba; lurasidone quetiapine; gain metabolic ... See more keywords